Our Products Work Together Seamlessly to Advance Drug Candidates
Biopharmaceuticals—whether they are bio-engineered proteins, nucleic acids, or microorganisms—are developed under close scrutiny by regulatory agencies such as the U.S. Food and Drug Administration and the European Medicines Agency. To ensure the integrity and safety of these compound, each must undergo rigorous processes and protocols. Supporting this effort, Agilent provides a collection of products that work together seamlessly to advance drug candidates from conception to reality. In simple terms, the company’s core biopharmaceutical products are designed to help you identify, measure, quantify, purify, and systematically reproduce target compounds on a large scale.
These technologies range from bench-top instruments to time-saving automated systems for processing, analyzing, and managing large amounts of data. Individually and in combination, Agilent technologies can help you complete these tasks with precision, confidence, and relative ease.